Renovaro Inc (RENB) Stock Price, Quote & News

Company Profile

Renovaro Inc., a pre-clinical stage biotechnology company, engages in the development of pharmaceutical and biological products for the treatment of cancer and HIV in the United States and the Netherlands. It operates through two segments, RENB and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an art...

Industry: Biotechnology

Sector: Healthcare

Phone: 305 918 1980

Website: renovarogroup.com

Address:

2080 Century Park East, Suite 906, Los Angeles, United States

paok44 Jun. 27 at 2:25 PM

$RENB RS 1/50

0 · Reply

Sewdot Jun. 26 at 1:55 PM

$RENB *this isn't from today* I just like it to be towards the top of the board 🤷

0 · Reply

mogluk Jun. 26 at 12:41 PM

$RENB hope it will stand on 0.4 this week

0 · Reply

Marketmoverjoe Jun. 25 at 7:24 PM

$RENB are we approaching a moment for this to run? or no

1 · Reply

JohnBallard648 Jun. 25 at 3:07 PM

$RENB markets an e-bike concept. AITX markets and delivers AI security trailers and agents in active use.

1 · Reply

riskmanagementsolutions Jun. 24 at 11:08 PM

$RENB Las empresas con una gestión incompetente son de las más fáciles para ganar dinero, así que esto debería ser pan comido para ti.

0 · Reply

paok44 Jun. 24 at 6:35 PM

$RENB Απο τις λιγες μετοχες που ειναι αρνητικη, μια μερα ανεβαινει τεσσερις παιφτει, δεν το γλιτωνει το RS. Η χειροτερη χρονια το 2025 και φυσικα μια ανεπαρκεις διοικηση.

0 · Reply

riskmanagementsolutions Jun. 24 at 10:20 AM

$RENB Pourquoi ne répondez-vous pas en anglais ?

0 · Reply

riskmanagementsolutions Jun. 24 at 10:17 AM

$RENB so why do you believe this is a scam? It’s only down a little bit and any bit of news could move it quickly.

0 · Reply

paok44 Jun. 23 at 6:40 PM

$RENB Από τα πολλά κέρδη το τελευταίο μισάωρο θα κλείσει αρνητική. Μεγάλη απάτη το 10-15% πάνω. Κάθε μερα εγκλωβιζουν αγοραστές σε αυτά τα επίπεδα. Η χρονιά 2025 χάθηκε πριν ξεκινήσει για όποιον δεν το κατάλαβε.

2 · Reply

Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform

May 22, 2025, 3:12 PM EDT - 5 weeks ago

UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

May 22, 2025, 11:05 AM EDT - 5 weeks ago

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

May 14, 2025, 9:15 AM EDT - 6 weeks ago

Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform

May 13, 2025, 9:15 AM EDT - 6 weeks ago

Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics

Apr 22, 2025, 9:20 AM EDT - 2 months ago

Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs

Apr 9, 2025, 9:25 AM EDT - 2 months ago

Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine

Apr 4, 2025, 9:40 AM EDT - 3 months ago

Renovaro Provides Update to Definitive Agreement with Predictive Oncology

Mar 3, 2025, 9:15 AM EST - 4 months ago

Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology

Feb 26, 2025, 1:25 PM EST - 4 months ago

Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine

Feb 26, 2025, 9:15 AM EST - 4 months ago

Renovaro Announces $15 million in Equity Committed

Jan 7, 2025, 6:51 PM EST - 6 months ago

PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI

POAI

Jan 7, 2025, 9:15 AM EST - 6 months ago

Renovaro Appoints Nathen Fuentes as Chief Financial Officer

Jan 7, 2025, 9:15 AM EST - 6 months ago

Renovaro Issues Shareholder Letter and Provides Corporate Update

Jan 6, 2025, 9:15 AM EST - 6 months ago

Renovaro to Acquire Predictive Oncology in All-Stock Transaction

Dec 30, 2024, 9:00 AM EST - 6 months ago

Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV

Dec 23, 2024, 9:00 AM EST - 6 months ago

RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program

Dec 20, 2024, 3:40 PM EST - 6 months ago

Renovaro Regains Compliance with NASDAQ Listing Requirement

Dec 20, 2024, 9:00 AM EST - 6 months ago

Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection

Oct 17, 2024, 9:15 AM EDT - 9 months ago

RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing

Oct 16, 2024, 9:28 AM EDT - 9 months ago

Renovaro Announces Strategic Restructuring and Leadership Transition

Sep 13, 2024, 9:00 AM EDT - 10 months ago

RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress

Sep 11, 2024, 9:15 AM EDT - 10 months ago

RenovaroCube Announces Strategic Offering of Up to 20% Ownership

Jun 14, 2024, 9:06 AM EDT - 1 year ago

Renovaro, Inc. Announces $10 million in Equity Committed

May 24, 2024, 9:20 AM EDT - 1 year ago

Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy

May 21, 2024, 8:39 AM EDT - 1 year ago

Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Renovaro (NASDAQ:RENB)

BAX RAPT SAGE TMCI

Apr 30, 2024, 11:00 AM EDT - 1 year ago

Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics

Apr 24, 2024, 9:00 AM EDT - 1 year ago

RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership

Apr 18, 2024, 8:45 AM EDT - 1 year ago

Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient C

Feb 15, 2024, 9:25 AM EST - 1 year ago

Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace

Feb 14, 2024, 10:01 AM EST - 1 year ago

Statement of Renovaro Inc

Feb 13, 2024, 9:31 AM EST - 1 year ago

AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine

Jan 25, 2024, 12:45 PM EST - 1 year ago

Renovaro Biosciences Announces Results of Special Meeting of Shareholders

Jan 16, 2024, 8:00 AM EST - 1 year ago

Message from Renovaro Bioscience, Inc.'s CEO, The Hon. Mark Dybul, MD

Jan 10, 2024, 5:21 PM EST - 1 year ago

RENOVARO BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Renovaro Biosciences Inc. - RENB

Oct 11, 2023, 9:25 AM EDT - 1 year ago

Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors

Oct 10, 2023, 8:00 AM EDT - 1 year ago

Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors

Oct 2, 2023, 12:05 PM EDT - 1 year ago

Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD

Oct 2, 2023, 9:25 AM EDT - 1 year ago

AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine

Sep 29, 2023, 9:15 AM EDT - 1 year ago

Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine

Sep 29, 2023, 9:15 AM EDT - 1 year ago

GEDi Cube and Renovaro Biosciences Sign Definitive Agreement to Combine

Aug 30, 2023, 9:15 AM EDT - 1 year ago

Renovaro BioSciences Welcomes GEDiCube Announcement of New Joint Effort

Aug 21, 2023, 9:15 AM EDT - 2 years ago

Renovaro BioSciences Congratulates GEDi Cube on Appointment of its Chief Medical Officer

Aug 9, 2023, 9:00 AM EDT - 2 years ago

AI Company GEDi Cube and Renovaro Biosciences Announce a Binding, Exclusive Letter of Intent to Merge, Accelerating Fight Against Cancer

Jun 23, 2023, 5:00 PM EDT - 2 years ago

Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder Meeting

Jun 8, 2023, 8:45 AM EDT - 2 years ago

Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA Review

Apr 3, 2023, 9:00 AM EDT - 2 years ago

Enochian BioSciences' CEO Letter to Shareholders

Mar 29, 2023, 9:00 AM EDT - 2 years ago

Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading Researcher

paok44 Jun. 27 at 2:25 PM

$RENB RS 1/50

0 · Reply

Sewdot Jun. 26 at 1:55 PM

$RENB *this isn't from today* I just like it to be towards the top of the board 🤷

0 · Reply

mogluk Jun. 26 at 12:41 PM

$RENB hope it will stand on 0.4 this week

0 · Reply

Marketmoverjoe Jun. 25 at 7:24 PM

$RENB are we approaching a moment for this to run? or no

1 · Reply

JohnBallard648 Jun. 25 at 3:07 PM

$RENB markets an e-bike concept. AITX markets and delivers AI security trailers and agents in active use.

1 · Reply

riskmanagementsolutions Jun. 24 at 11:08 PM

$RENB Las empresas con una gestión incompetente son de las más fáciles para ganar dinero, así que esto debería ser pan comido para ti.

0 · Reply

paok44 Jun. 24 at 6:35 PM

0 · Reply

riskmanagementsolutions Jun. 24 at 10:20 AM

$RENB Pourquoi ne répondez-vous pas en anglais ?

0 · Reply

riskmanagementsolutions Jun. 24 at 10:17 AM

$RENB so why do you believe this is a scam? It’s only down a little bit and any bit of news could move it quickly.

0 · Reply

paok44 Jun. 23 at 6:40 PM

2 · Reply

WolverineVcapitalllc Jun. 23 at 3:50 PM

$CRCL $RENB $BULL

0 · Reply

paok44 Jun. 23 at 3:26 PM

$RENB Στο κλεισιμο παλι αρνητικη, μεγαλη απατη.

0 · Reply

Marketmoverjoe Jun. 23 at 3:00 PM

$RENB funny how every ticker's movement is different. We all know this is bound to pop, but it's painful to watch

0 · Reply

WolverineVcapitalllc Jun. 22 at 9:12 PM

$CRCL the roa on $RENB and it’s patent is to look at I have 250 shares after the

0 · Reply

AKtradess Jun. 20 at 3:49 PM

$RENB whats the deal here?

1 · Reply

Yassin_tet Jun. 19 at 7:15 AM

$RENB no movement at all here

0 · Reply

Plain360 Jun. 18 at 5:44 PM

Bought the following $CRDF $RENB and $NCL all paid for by $TMC put options.

1 · Reply

Aristoteli Jun. 18 at 12:18 PM

$RENB soon $1 and no R/S this is the stonk

1 · Reply

mogluk Jun. 16 at 5:04 PM

$RENB now shorter and buyer are fighting.

0 · Reply

BALLER808 Jun. 16 at 8:00 AM

$RENB 😝😝

0 · Reply

Yassin_tet Jun. 13 at 12:32 PM

$RENB the market is again deep red because of the Monster in the middle east ... destroying everything close by

0 · Reply

Aristoteli Jun. 13 at 9:15 AM

$RENB is warming up the machine

0 · Reply

Market Cap	61.57M
Revenue (ttm)	0.00
Net Income (ttm)	-80.65M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	379,167
Avg Vol	3,797,670
Day's Range	N/A - N/A
Shares Out	172.12M
Stochastic %K	38%
Beta	0.55
Analysts	Strong Buy
Price Target	N/A